Akinyemi Oni-Orisan, PharmD, PhD

Associate Professor
Anna Wu
Phone: +1 415 502-7551
Fax: +1 415 476-6632
521 Parnassus Avenue, Rm 3602
UCSF Box 0622
San Francisco, CA 94117
United States


What I do

My lab conducts computational research investigating therapies for cardiovascular disease using observational data from electronic health records. I also teach pharmacy students in the Discovery Projects research program including leading the Health Disparities Discovery Group and serving as a primary mentor for students in the Pharmacogenomics Discovery Group.

Departmental research area

My research expertise

pharmacogenomics, pharmacoepidemiology, clinical research in historically minoritized groups, electronic health records

Clinical expertise

cardiovascular disease risk reduction, lipid management

Professional background


The long-term research goal of Dr. Oni-Orisan’s lab is to improve pharmacological regimens for the prevention and treatment of cardiovascular disease in diverse populations through precision medicine. To accomplish this objective, his group combines computational approaches in pharmacogenomics and pharmacoepidemiology using electronic health record-linked biobanks. His lab is currently funded to investigate genetic determinants of efficacy and safety for statin therapy in diverse populations.

Dr. Oni-Orisan teaches and mentors pharmacy students in the Discovery Projects research program including leading the inaugural Health Disparities Discovery Group.

Dr. Oni-Orisan serves as Diversity Leader for the Department of Clinical Pharmacy to champion diversity, equity and inclusion (DEI) efforts in the department.

Research keywords

  • pharmacogenomics
  • health disparities
  • Cardiovascular drugs
  • Cytochrome P-450 CYP2D6
  • Cardiovascular Agents
  • Amino Acid Substitution
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Eicosanoids
  • Epoxide Hydrolases
  • Arachidonic Acids
  • precision medicine
  • Cholesterol, LDL
  • Arachidonic Acid
  • pharmacogenetics
  • Patient Acuity
  • Drug-Related Side Effects and Adverse Reactions
  • Cytochrome P-450 Enzyme System
  • Lovastatin